Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

December 1, 2021; Volume 62,Issue 12

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 10A;

Discussions with Leaders

  • You have access
    Molecular Imaging Leadership in Academia and Industry
    Mark Mintun and David Mankoff 
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1657-1659; DOI: https://doi.org/10.2967/jnumed.121.263451

The State of The Art

  • You have access
    Radionuclide Therapy in Prostate Cancer: From Standalone to Combination PSMA Theranostics
    Shahneen Sandhu, Christina Guo and Michael S. Hofman
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1660-1668; DOI: https://doi.org/10.2967/jnumed.120.243295

Hot Topics

  • You have access
    Radioembolization Versus Bland or Chemoembolization for Liver-Dominant Neuroendocrine Tumors: Is It an Either/Or Question?
    Strosberg Jonathan, Ghassan El-Haddad, Taymeyah Al-Toubah, Diane Reidy-Lagunes, Etay Ziv, Armeen Mahvash, Arvind Dasari, Philip A. Philip and Michael C. Soulen
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1669-1671; DOI: https://doi.org/10.2967/jnumed.121.263041

Focus on Molecular Imaging

  • You have access
    Building the Bridge: Molecular Imaging Biomarkers for 21st Century Cancer Therapies
    Mark A. Sellmyer, Iris K. Lee and David A. Mankoff
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1672-1676; DOI: https://doi.org/10.2967/jnumed.121.262484

Oncology

  • Clinical

    • Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including <sup>18</sup>F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard
      You have access
      Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard
      Janna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, Tim Ullrich, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Lena Häberle, Marc Ingenwerth, Lale Umutlu, Wolfgang Peter Fendler, Tanja Fehm, Ken Herrmann, Gerald Antoch, Lino Morris Sawicki and Julian Kirchner
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1677-1683; DOI: https://doi.org/10.2967/jnumed.121.262009
    • Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
      Open Access
      Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
      Maja Guberina, Christoph Pöttgen, Martin Metzenmacher, Marcel Wiesweg, Martin Schuler, Clemens Aigner, Till Ploenes, Lale Umutlu, Thomas Gauler, Kaid Darwiche, Georgios Stamatis, Dirk Theegarten, Hubertus Hautzel, Walter Jentzen, Nika Guberina, Ken Herrmann, Wilfried E.E. Eberhardt and Martin Stuschke
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1684-1691; DOI: https://doi.org/10.2967/jnumed.120.260646
    • Transarterial Radioembolization Versus Systemic Treatment for Hepatocellular Carcinoma with Macrovascular Invasion: Analysis of the U.S. National Cancer Database
      You have access
      Transarterial Radioembolization Versus Systemic Treatment for Hepatocellular Carcinoma with Macrovascular Invasion: Analysis of the U.S. National Cancer Database
      Joseph C. Ahn, Marie Lauzon, Michael Luu, Marc L. Friedman, Kambiz Kosari, Nicholas Nissen, Shelly C. Lu, Lewis R. Roberts, Amit G. Singal and Ju Dong Yang
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1692-1701; DOI: https://doi.org/10.2967/jnumed.121.261954
    • Minimal Extrathyroidal Extension in Papillary Thyroid Microcarcinoma Is an Independent Risk Factor for Relapse Through Lymph Node and Distant Metastases
      You have access
      Minimal Extrathyroidal Extension in Papillary Thyroid Microcarcinoma Is an Independent Risk Factor for Relapse Through Lymph Node and Distant Metastases
      Robert Seifert, Michael Schäfers, Barbara Heitplatz, Laura Kerschke, Burkhard Riemann and Benjamin Noto
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1702-1709; DOI: https://doi.org/10.2967/jnumed.121.261898

Theranostics

  • Clinical

    • EDITORIAL

      • You have access
        Bringing VISION to Nuclear Medicine: Accelerating Evidence and Changing Paradigms with Theranostics
        Michael S. Hofman
        Journal of Nuclear Medicine December 1, 2021, 62 (12) 1710-1711; DOI: https://doi.org/10.2967/jnumed.121.262890
    • Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE
      Open Access
      Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
      Jonathan R. Strosberg, Rajaventhan Srirajaskanthan, Ghassan El-Haddad, Edward M. Wolin, Beth A. Chasen, Matthew H. Kulke, David L. Bushnell, Martyn E. Caplin, Richard P. Baum, Andrew E. Hendifar, Kjell Öberg, Philippe Ruszniewski, Paola Santoro, Per Broberg, Oscar R. Leeuwenkamp, Eric P. Krenning and for the NETTER-1 study group
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1712-1718; DOI: https://doi.org/10.2967/jnumed.120.258897
    • Detection Efficacy of <sup>18</sup>F‐rhPSMA‐7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment
      You have access
      Detection Efficacy of 18F‐rhPSMA‐7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment
      Isabel Rauscher, Amir Karimzadeh, Kilian Schiller, Thomas Horn, Calogero D’Alessandria, Charlott Franz, Hannah Wörther, Noemi Nguyen, Stephanie E. Combs, Wolfgang A. Weber and Matthias Eiber
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1719-1726; DOI: https://doi.org/10.2967/jnumed.120.260091
    • A Phase II, Open-Label Study to Assess Safety and Management Change Using <sup>68</sup>Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
      You have access
      A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
      Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J.R. Cook, Marie Meagher, Dimitrios Priftakis, Victoria S. Warbey, Anand Kelkar, Clement Orczyk, Anita Mitra, Sarah Needleman, Michael Ferris, Greg Mullen and Jamshed Bomanji
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1727-1734; DOI: https://doi.org/10.2967/jnumed.120.257527
    • Tumor Detection of <sup>18</sup>F-PSMA-1007 in the Prostate Gland in Patients with Prostate Cancer Using Prostatectomy Specimens as Reference Method
      You have access
      Tumor Detection of 18F-PSMA-1007 in the Prostate Gland in Patients with Prostate Cancer Using Prostatectomy Specimens as Reference Method
      Elin Trägårdh, Athanasios Simoulis, Anders Bjartell and Jonas Jögi
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1735-1740; DOI: https://doi.org/10.2967/jnumed.121.261993
    • Assessing Response to <sup>177</sup>Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
      You have access
      Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
      Kerstin Michalski, Claudius Klein, Tonio Brüggemann, Philipp T. Meyer, Cordula A. Jilg and Juri Ruf
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1741-1746; DOI: https://doi.org/10.2967/jnumed.120.260836
    • BRIEF COMMUNICATION

      • PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease
        You have access
        PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease
        Francesco Barbato, Wolfgang P. Fendler, Isabel Rauscher, Ken Herrmann, Axel Wetter, Justin Ferdinandus, Robert Seifert, Michael Nader, Kambiz Rahbar, Boris Hadaschik, Matthias Eiber, Andrei Gafita and Manuel Weber
        Journal of Nuclear Medicine December 1, 2021, 62 (12) 1747-1750; DOI: https://doi.org/10.2967/jnumed.121.262120

Radionuclide Therapy

  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Improved <sup>223</sup>Ra Therapy with Combination Epithelial Sodium Channel Blockade
        Open Access
        Improved 223Ra Therapy with Combination Epithelial Sodium Channel Blockade
        Diane S. Abou, Amanda Fears, Lucy Summer, Mark Longtine, Nadia Benabdallah, Ryan C. Riddle, David Ulmert, Jeff M. Michalski, Richard L. Wahl, Denise Chesner, Michele Doucet, Nicholas C. Zachos, Brian W. Simons and Daniel L.J. Thorek
        Journal of Nuclear Medicine December 1, 2021, 62 (12) 1751-1758; DOI: https://doi.org/10.2967/jnumed.121.261977

Cardiovascular

  • Clinical

    • Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in <sup>18</sup>F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis
      You have access
      Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in 18F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis
      Can Özütemiz, Yasemin Koksel, Jerry W. Froelich, Nathan Rubin, Maneesh Bhargava, Henri Roukoz, Rebecca Cogswell, Jeremy Markowitz, David M. Perlman and Daniel Steinberger
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1759-1767; DOI: https://doi.org/10.2967/jnumed.121.261981
    • MRI-Guided Motion-Corrected PET Image Reconstruction for Cardiac PET/MRI
      Open Access
      MRI-Guided Motion-Corrected PET Image Reconstruction for Cardiac PET/MRI
      Camila Munoz, Sam Ellis, Stephan G. Nekolla, Karl P. Kunze, Teresa Vitadello, Radhouene Neji, Rene M. Botnar, Julia A. Schnabel, Andrew J. Reader and Claudia Prieto
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1768-1774; DOI: https://doi.org/10.2967/jnumed.120.254235

Neurology

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • Dynamic <sup>18</sup>F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
        You have access
        Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
        Shichun Peng, Chris Tang, Katharina Schindlbeck, Yaacov Rydzinski, Vijay Dhawan, Phoebe G. Spetsieris, Yilong Ma and David Eidelberg
        Journal of Nuclear Medicine December 1, 2021, 62 (12) 1775-1782; DOI: https://doi.org/10.2967/jnumed.120.257345
    • Frontal Hypometabolism in Neurocognitive Disorder with Behavioral Disturbance
      You have access
      Frontal Hypometabolism in Neurocognitive Disorder with Behavioral Disturbance
      Christine Bastin, Mohamed Ali Bahri, Claire Bernard, Roland Hustinx and Eric Salmon
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1783-1788; DOI: https://doi.org/10.2967/jnumed.120.260497
  • Basic

    • A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model
      You have access
      A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model
      Lucas Narciso, Tracy Ssali, Linshan Liu, Heather Biernaski, John Butler, Laura Morrison, Jennifer Hadway, Jeffrey Corsaut, Justin W. Hicks, Michael C. Langham, Felix W. Wehrli, Hidehiro Iida and Keith St Lawrence
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1789-1796; DOI: https://doi.org/10.2967/jnumed.120.260521

Molecular Imaging

  • Basic

    • Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms
      You have access
      Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms
      Lukas M. Carter, Chansoo Choi, Simone Krebs, Bradley J. Beattie, Chan Hyeong Kim, Heiko Schoder, Wesley E. Bolch and Adam L. Kesner
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1805-1814; DOI: https://doi.org/10.2967/jnumed.120.256719

Radiobiology/Dosimetry

  • Basic

    • Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues
      You have access
      Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues
      Frans V. Suurs, Grit Lorenczewski, Julie M. Bailis, Sabine Stienen, Matthias Friedrich, Fei Lee, Bert van der Vegt, Elisabeth G.E. de Vries, Derk Jan A. de Groot and Marjolijn N. Lub-de Hooge
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1797-1804; DOI: https://doi.org/10.2967/jnumed.120.259036

Infectious Disease

  • Clinical

    • You have access
      Appropriate Use Criteria for the Use of Nuclear Medicine in Musculoskeletal Infection Imaging
      Christopher J. Palestro, Alicia Clark, Erin E. Grady, Sherif Heiba, Ora Israel, Alan Klitzke, Charito Love, Mike Sathekge, Treves Ted and Tracy L. Yarbrough
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1815-1831; DOI: https://doi.org/10.2967/jnumed.121.262579

Letters To The Editor

  • Open Access
    Houdini’s Illusions: Some Acts Are Not What They Seem to Be
    Roelof J. Bennink, Mathias Prokop, Andor W. J. M. Glaudemans, Liesbeth Peters-Bax, Jasper H. G. Helthuis, Arthur Adams, Peter R. Kornaat, Adriaan A. Lammertsma and Lenka M. Pereira Arias-Bouda
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1832; DOI: https://doi.org/10.2967/jnumed.121.262631
  • You have access
    Cut Point Identification of Continuous Biomarkers: A Challenge That Goes Beyond Statistical Aspects
    Paulo Schiavom Duarte
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1833; DOI: https://doi.org/10.2967/jnumed.121.262905

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 11N-22N;
  • Open Access
    2021 SNMMI Highlights Lecture: Neuroscience
    Julie Price
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 11N-17N;
  • You have access
    Interim Report on Provisional Requirements for Radionuclide Therapy
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 18N;
  • You have access
    SNMMI Mid-Winter and ACNM Annual Meeting Convene In-Person
    Virginia Pappas
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 19N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 20N-22N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (12)
Journal of Nuclear Medicine
Vol. 62, Issue 12
December 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
  • Improved 223Ra Therapy with Combination Epithelial Sodium Channel Blockade
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of The Art
  • Hot Topics
  • Focus on Molecular Imaging
  • Oncology
    • Clinical
  • Theranostics
    • Clinical
      • EDITORIAL
      • BRIEF COMMUNICATION
  • Radionuclide Therapy
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Cardiovascular
    • Clinical
  • Neurology
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
    • Basic
  • Molecular Imaging
    • Basic
  • Radiobiology/Dosimetry
    • Basic
  • Infectious Disease
    • Clinical
  • Letters To The Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire